BlackRock, Inc. 13D and 13G filings for Amylyx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Sale |
2024-06-30 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
BLACKROCK INC BLK |
2,669,741 3.900% |
-1,332,593 (-33.30%) |
Filing |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
BLACKROCK INC BLK |
4,002,334 5.900% |
385,408 (+10.66%) |
Filing |
| 2023-02-13 2:27 pm Purchase |
2022-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
BLACKROCK INC BLK |
3,616,926 5.500% |
3,616,926 (New Position) |
Filing |